These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

988 related items for PubMed ID: 18372589

  • 21. [Prevalence of atrophic gastritis in different populations in Siberia on medical evidence of the serological survey].
    Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA, Bessonov PP, Vasil'ev RR, Tatarinova OV, Muchina EG.
    Klin Med (Mosk); 2008; 86(7):35-8. PubMed ID: 18756745
    [Abstract] [Full Text] [Related]

  • 22. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study.
    Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Mernova VP, Polyakova MB.
    Scand J Gastroenterol; 2005 Mar; 40(3):297-301. PubMed ID: 15932170
    [Abstract] [Full Text] [Related]

  • 23. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M, Valle J, Härkönen M, Maaroos HI, Peetsalu A.
    Hepatogastroenterology; 2005 Mar; 52(63):785-91. PubMed ID: 15966205
    [Abstract] [Full Text] [Related]

  • 24. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 25. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
    Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, Jellum E, McColl KE.
    Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
    [Abstract] [Full Text] [Related]

  • 26. Screening markers for chronic atrophic gastritis in Chiapas, Mexico.
    Ley C, Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J.
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):107-12. PubMed ID: 11219766
    [Abstract] [Full Text] [Related]

  • 27. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
    Colarossi A, Inga R, Prochazka R, Reyes U, Bussalleu A, Barúa RL.
    Rev Gastroenterol Peru; 2011 Feb; 31(2):110-5. PubMed ID: 21836650
    [Abstract] [Full Text] [Related]

  • 28. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K.
    J Gastroenterol; 2003 Feb; 38(4):332-8. PubMed ID: 12743772
    [Abstract] [Full Text] [Related]

  • 29. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N, Katsuragi K, Maeda K, Sawada T, Wakasa K, Hirakawa K.
    Hepatogastroenterology; 2006 Feb; 53(70):619-23. PubMed ID: 16995475
    [Abstract] [Full Text] [Related]

  • 30. Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study.
    Peitz U, Wex T, Vieth M, Stolte M, Willich S, Labenz J, Jaspersen D, Lind T, Malfertheiner P.
    J Gastroenterol Hepatol; 2011 Jan; 26(1):82-9. PubMed ID: 21175799
    [Abstract] [Full Text] [Related]

  • 31. [Chronic gastritis: last decade's achievements and problems].
    Pimanov SI, Makarenko EV.
    Klin Med (Mosk); 2005 Jan; 83(1):54-8. PubMed ID: 15759493
    [Abstract] [Full Text] [Related]

  • 32. Value of serology (ELISA) for the diagnosis of Helicobacter pylori infection: evaluation in patients attending endoscopy and in those with fundic atrophic gastritis.
    Tucci A, Poli L, Donati M, Mazzoni C, Cevenini R, Sambri V, Varoli O, Bocus P, Ferrari A, Paparo GF, Caletti G.
    Ital J Gastroenterol; 1996 Sep; 28(7):371-6. PubMed ID: 8937937
    [Abstract] [Full Text] [Related]

  • 33. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
    Chae H, Lee JH, Lim J, Kim M, Kim Y, Han K, Kang CS, Shim SI, Kim JI, Park SH.
    Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
    [Abstract] [Full Text] [Related]

  • 34. Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study.
    Dong Z, Zhang X, Chen X, Zhang J.
    Clin Lab; 2019 Dec 01; 65(12):. PubMed ID: 31414587
    [Abstract] [Full Text] [Related]

  • 35. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
    Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandström R, Ristikankare M, Jussila A, Sipponen P.
    Eur J Gastroenterol Hepatol; 2003 Aug 01; 15(8):885-91. PubMed ID: 12867799
    [Abstract] [Full Text] [Related]

  • 36. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K, Kamada T, Ito M, Kaya S, Tanaka A, Kusunoki H, Hata J, Haruma K.
    Dig Liver Dis; 2006 May 01; 38(5):303-7. PubMed ID: 16549394
    [Abstract] [Full Text] [Related]

  • 37. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel® Test.
    Koivurova OP, Koskela R, Blomster T, Ala-Rämi A, Lumme H, Kettunen O, Hukkanen J, Karttunen TJ, Mäkinen M, Ronkainen J, Syrjänen K.
    Anticancer Res; 2021 Nov 01; 41(11):5527-5537. PubMed ID: 34732423
    [Abstract] [Full Text] [Related]

  • 38. Association between serum pepsinogen A and C levels, serum gastrin concentrations and Helicobacter pylori antibodies.
    Kullich W, Pöllmann G, Czerwenka C, Klein G.
    Wien Med Wochenschr; 1999 Nov 01; 149(7):157-61. PubMed ID: 10413837
    [Abstract] [Full Text] [Related]

  • 39. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M.
    Int J Cancer; 2014 Mar 15; 134(6):1445-57. PubMed ID: 24009139
    [Abstract] [Full Text] [Related]

  • 40. Comparison between serology and histology in the diagnosis of advanced gastric body atrophy: a study in a Dutch primary community.
    Korstanje A, van Eeden S, Offerhaus JA, Waltman FL, Hartog Gd, Roelandse FW, Souverijn JH, Biemond I, Lamers CB.
    J Clin Gastroenterol; 2008 Jan 15; 42(1):18-22. PubMed ID: 18097284
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.